APA (7th ed.) Citation

W, K., S, C., A, B., G, F., S, F., U, S., . . . LC, H. (2021). High stroma-derived WNT5A is an indicator for low-risk prostate cancer. FEBS open bio, 11(4), 1186. https://doi.org/10.1002/2211-5463.13131

Chicago Style (17th ed.) Citation

W, Kisel, et al. "High Stroma-derived WNT5A Is an Indicator for Low-risk Prostate Cancer." FEBS Open Bio 11, no. 4 (2021): 1186. https://doi.org/10.1002/2211-5463.13131.

MLA (9th ed.) Citation

W, Kisel, et al. "High Stroma-derived WNT5A Is an Indicator for Low-risk Prostate Cancer." FEBS Open Bio, vol. 11, no. 4, 2021, p. 1186, https://doi.org/10.1002/2211-5463.13131.